A provider of quality investment and wealth management resources, Enviso Capital was ranked among the Top 25 Southern California Investment Firms by the San Diego Business Journal. Enviso Capital is active in a variety of growing niche sectors, including the proton therapy marketplace.
Proton therapy, an innovative cancer treatment that harnesses the power of extremely precise proton beams to eradicate cancer, is increasing in popularity worldwide, driven by consumer demand for proton therapy facilities and specialized equipment. For example, a leader in proton therapy machine manufacture recently hired hundreds more workers in light of robust sales.
In the past, the high cost of the therapy relative to traditional cancer treatments prevented its proliferation. Just one proton facility can cost up to $200 million. Despite such heady initial investments, however, the number of such facilities has doubled since 2011. Moreover, technical advances have resulted in the design of proton-beam delivery systems that cost much less than older-generation technology.
North America hosts the largest number of proton therapy providers in the world. Recent years have seen its popularity grow in Europe and Asia as well.